Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved crawled date : 2021 - 12 - 29 save search
Eagle Pharmaceuticals Receives 180 Days of Marketing Exclusivity for Recently Approved Vasopressin
Published: 2021-12-29 (Crawled : 21:00) - biospace.com/
EGRX | $4.63 3.35% 3.24% 60K
|
Health Technology
|
| O: -0.08%
H: 0.38%
C: -1.21%
als
Lexaria Receives Independent Review Board Approval For DehydraTECH-CBD Human Clinical Study HYPER-H21-4
Published: 2021-12-29 (Crawled : 21:00) - biospace.com/
LEXX | $2.27 0.89% 0.88% 62K
|
Health Technology
|
| O: -0.97%
H: 9.57%
C: -5.61%
cbd approval
Janssen Submits Biologics License Application to U.S. FDA Seeking Approval of Teclistamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Published: 2021-12-29 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.21%
H: 1.17%
C: 0.91%
treatment fda application license approval
THE HOWARD HUGHES CORPORATION® ANNOUNCES APPROVAL OF $850 MILLION DEVELOPMENT PROJECT FOR 250 WATER STREET AT THE SEAPORT IN LOWER MANHATTAN
Published: 2021-12-29 (Crawled : 14:00) - prnewswire.com
HHC 4 | $78.76 0.15% 0.0% 0
|
Finance
|
| O: -0.09%
H: 1.29%
C: 0.21%
corporation approval
Finward Bancorp and Royal Financial, Inc. Announce Receipt of Regulatory Approvals and Election Deadline
Published: 2021-12-29 (Crawled : 13:30) - globenewswire.com
FNWD 4 | $24.64 -0.73% -0.73% 3.7K
|
Finance and Insurance
|
| O: -1.92%
H: 0.0%
C: 0.0%
als approval deadline
Paragon 28, Inc. R3ACT™ Stabilization System Cleared by FDA
Published: 2021-12-29 (Crawled : 13:00) - biospace.com/
FNA 4 | $9.8 1.55% 0.0% 450K
|
|
| O: 0.36%
H: 2.15%
C: 0.97%
fda system
NRx Pharmaceuticals Files Breakthrough Therapy Designation Request for ZYESAMI® (aviptadil) in Patients at Immediate Risk of Death from COVID-19 Despite Treatment with Remdesivir and Other Approved Therapies
Published: 2021-12-29 (Crawled : 12:30) - biospace.com/
NRXP 2 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: 10.22%
H: 4.84%
C: 0.2%
covid-19 zyesami treatment aviptadil als risk covid media therapy breakthrough therapy designation
Amphastar Receives FDA Tentative Approval for Vasopressin
Published: 2021-12-29 (Crawled : 12:00) - biospace.com/
AMPH | $39.98 3.44% 3.33% 410K
|
Health Technology
|
| O: 0.26%
H: 0.87%
C: 0.17%
fda tentative star approval
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.